Simplex Trading, LLC Intellia Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 78,994 shares of NTLA stock, worth $962,146. This represents 0.06% of its overall portfolio holdings.

Number of Shares

78,994

Previous 40,788 93.67%

Holding current value

$962,146

Previous $912,000 77.96%

% of portfolio

0.06%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$19.72 - $27.36 $753,422 - $1.05 Million	38,206 Added 93.67%	78,994 $1.62 Million
Q2 2024 Jul 25, 2024	SELL	$20.02 - $27.22 $478,177 - $650,149	-23,885 Reduced 36.93%	40,788 $912,000
Q1 2024 Apr 25, 2024	BUY	$23.82 - $32.8 $1.26 Million - $1.74 Million	52,922 Added 450.36%	64,673 $1.78 Million
Q4 2023 Feb 02, 2024	BUY	$23.16 - $32.34 $272,153 - $380,027	11,751 New	11,751 $358,000
Q2 2023 Aug 04, 2023	BUY	$34.58 - $46.03 $1.05 Million - $1.4 Million	30,490 Added 517.13%	36,386 $1.48 Million
Q1 2023 Apr 27, 2023	BUY	$33.3 - $44.82 $134,765 - $181,386	4,047 Added 218.88%	5,896 $219,000
Q4 2022 Feb 02, 2023	SELL	$33.21 - $62.69 $6,475 - $12,224	-195 Reduced 9.54%	1,849 $64,000
Q3 2022 Nov 04, 2022	BUY	$53.92 - $71.7 $110,212 - $146,554	2,044 New	2,044 $114,000
Q2 2022 Aug 03, 2022	SELL	$38.49 - $76.21 $33,101 - $65,540	-860 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$58.27 - $118.99 $86,414 - $176,462	-1,483 Reduced 63.29%	860 $62,000
Q4 2021 Feb 23, 2022	SELL	$100.76 - $138.36 $553,373 - $759,873	-5,492 Reduced 70.1%	2,343 $277,000
Q3 2021 Oct 28, 2021	BUY	$132.37 - $176.78 $972,654 - $1.3 Million	7,348 Added 1508.83%	7,835 $1.34 Million
Q2 2021 Aug 12, 2021	SELL	$60.88 - $161.91 $72,447 - $192,672	-1,190 Reduced 70.96%	487 $78,000
Q1 2021 Apr 26, 2021	BUY	$46.59 - $83.68 $78,131 - $140,331	1,677 New	1,677 $134,000
Q3 2020 Oct 14, 2020	SELL	$17.47 - $24.93 $438,706 - $626,042	-25,112 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$11.14 - $22.87 $33 - $68	-3 Reduced 0.01%	25,112 $527,000
Q1 2020 Apr 29, 2020	BUY	$9.44 - $15.58 $237,085 - $391,291	25,115 New	25,115 $307,000
Q2 2019 Jul 26, 2019	SELL	$13.88 - $18.41 $250,242 - $331,913	-18,029 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$12.79 - $17.62 $183,677 - $253,040	14,361 Added 391.52%	18,029 $0
Q4 2018 Jan 16, 2019	SELL	$11.39 - $27.13 $125,825 - $299,705	-11,047 Reduced 75.07%	3,668 $50,000
Q3 2018 Oct 23, 2018	SELL	$25.78 - $32.6 $240,372 - $303,962	-9,324 Reduced 38.79%	14,715 $421,000
Q2 2018 Jul 30, 2018	BUY	$20.02 - $30.79 $63,303 - $97,357	3,162 Added 15.15%	24,039 $657,000
Q1 2018 Apr 26, 2018	SELL	$19.43 - $34.95 $521,520 - $938,092	-26,841 Reduced 56.25%	20,877 $440,000
Q4 2017 Jan 10, 2018	BUY	$17.39 - $31.12 $733,892 - $1.31 Million	42,202 Added 765.08%	47,718 $917,000
Q3 2017 Oct 25, 2017	BUY	$15.16 - $25.75 $83,622 - $142,037	5,516	5,516 $137,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Intellia Therapeutics, Inc. Transaction History